ECSP003314A - DELAYED DRUG FORMULATIONS CONTAINING A COMBINATION OF AN OPIOID AND AN - AGONIST - Google Patents
DELAYED DRUG FORMULATIONS CONTAINING A COMBINATION OF AN OPIOID AND AN - AGONISTInfo
- Publication number
- ECSP003314A ECSP003314A ECSP003314A ECSP003314A EC SP003314 A ECSP003314 A EC SP003314A EC SP003314 A ECSP003314 A EC SP003314A EC SP003314 A ECSP003314 A EC SP003314A
- Authority
- EC
- Ecuador
- Prior art keywords
- opioid
- agonist
- combination
- formulations containing
- drug formulations
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title abstract 2
- 230000003111 delayed effect Effects 0.000 title abstract 2
- 239000013583 drug formulation Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Formulaciones medicamentosas retardadas que contienen una combinaciòn de un opioide o una sal fisiològicamente tolerable del mismo, un agonista o una sal fisiològicamente tolerable del mismo, conjuntamnete con lactosa o fosfato monoàcido càlcico, con o sin otros excipinetes farmacèuticos, asi como su uso en estados àlgicos de mediana intensidad hasta agudos severos o crtònicos.Delayed medicinal formulations containing a combination of an opioid or a physiologically tolerable salt thereof, an agonist or a physiologically tolerable salt thereof, together with lactose or calcium monoacid phosphate, with or without other pharmaceutical excipines, as well as its use in allergic states of medium intensity to severe or critical acute.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003314 ECSP003314A (en) | 2000-01-11 | 2000-01-11 | DELAYED DRUG FORMULATIONS CONTAINING A COMBINATION OF AN OPIOID AND AN - AGONIST |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003314 ECSP003314A (en) | 2000-01-11 | 2000-01-11 | DELAYED DRUG FORMULATIONS CONTAINING A COMBINATION OF AN OPIOID AND AN - AGONIST |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003314A true ECSP003314A (en) | 2000-03-22 |
Family
ID=42040945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003314 ECSP003314A (en) | 2000-01-11 | 2000-01-11 | DELAYED DRUG FORMULATIONS CONTAINING A COMBINATION OF AN OPIOID AND AN - AGONIST |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003314A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9700508B2 (en) | 2010-05-10 | 2017-07-11 | Euro-Celtique S.A. | Pharmaceutical compositions comprising hydromorphone and naloxone |
| US9901540B2 (en) | 2010-05-10 | 2018-02-27 | Euro-Celtique S.A. | Combination of active loaded granules with additional actives |
| US10076498B2 (en) | 2006-08-25 | 2018-09-18 | Purdue Pharma L.P. | Tamper resistant dosage forms |
-
2000
- 2000-01-11 EC ECSP003314 patent/ECSP003314A/en unknown
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10076498B2 (en) | 2006-08-25 | 2018-09-18 | Purdue Pharma L.P. | Tamper resistant dosage forms |
| US10076499B2 (en) | 2006-08-25 | 2018-09-18 | Purdue Pharma L.P. | Tamper resistant dosage forms |
| US9700508B2 (en) | 2010-05-10 | 2017-07-11 | Euro-Celtique S.A. | Pharmaceutical compositions comprising hydromorphone and naloxone |
| US9901540B2 (en) | 2010-05-10 | 2018-02-27 | Euro-Celtique S.A. | Combination of active loaded granules with additional actives |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR022252A1 (en) | ORAL ADMINISTRATION COMPOSITION. | |
| EA199800946A1 (en) | CONCENTRATED ANTIBODY PREPARATION | |
| ES2162517T3 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF METFORMIN AND FIBRATE AND ITS USE IN THE PREPARATION OF DRUGS INTENDED TO REDUCE HYPERGLYCEMIA. | |
| DE60108154D1 (en) | Pharmaceutical preparations containing clavulanic acid | |
| ES2195638T3 (en) | PREPARATIONS OF PHARMACEUTICAL COMBINATIONS IN SOLID FORM OF DOSAGE CONTAINING CARDEVILOL AND HYDROCLOROTIAZIDA. | |
| AR039378A1 (en) | PHARMACEUTICAL PREPARATION CONTAINING OXYCODONE AND NALOXONE | |
| PT893992E (en) | FORMS OF FAST DISINTEGRATION ORAL DOSAGE | |
| UY27940A1 (en) | FORMULATION OF HUMAN ANTIBODIES FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH TNF-A | |
| SV2004001556A (en) | ACID PREPARATIONS OF INSULIN WITH IMPROVED STABILITY | |
| DE60131760D1 (en) | DEVICE FOR THE ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE ACTIVE IN POWDER FORM | |
| CY1108532T1 (en) | UNIONS AND COMPOSITIONS FOR PROVIDING ACTIVE AGENTS | |
| AR042937A2 (en) | SUSTAINED RELEASE FORMULATIONS FOR GROWTH HORMONE SECRETAGOGS | |
| BR0012082A (en) | Pharmaceutical formulation for administration comprising morphine and its use | |
| ES2156840T1 (en) | MEDICINAL PRODUCT CONTAINING PENTOSANE POLYSULFATE AND IMPLANT TO TREAT FIBROSIS. | |
| MX9204268A (en) | A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME. | |
| ATE259658T1 (en) | ANESTHETICAL PREPARATION CONTAINING AN NMDA ANTAGONIST AND AN ALPHA-2 ADRENERGIC AGONIST | |
| DK0776202T3 (en) | Liposomally encapsulated taxol, its preparation for its use | |
| BR0014818A (en) | Bicyclic imidazo-3-yl-amines preparation procedure and drugs containing at least one bicyclic imidazo-3-yl-amines | |
| AR032293A1 (en) | PHARMACEUTICAL CASE | |
| PT1112266E (en) | SUBSTITUTED 4-AMINO-2-ARYL-PYRIMIDINES, ITS PREPARATION, ITS USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| DE69932510D1 (en) | VASKULARISIERUNGSINHIBITOREN | |
| ATE260650T1 (en) | ORAL DOSAGE FORMS FOR ADMINISTRATION OF A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC | |
| AR025330A1 (en) | COMBINATION OF ACTIVE SUBSTANCES WITH CLONIDINE | |
| AR031761A1 (en) | REPINOTANE KIT | |
| CO5640094A2 (en) | A PHARMACEUTICAL COMPOSITION INCLUDING A P2X7 RECEIVER ANTAGONIST AND AN ALPHUS TUMOR NECROSIS FACTOR |